Institut Rosell-Lallemand announces the latest addition to its immune support range: ProbioKid® Vita+. Marketed as a natural solution to maintain the body’s natural defenses, ProbioKid® Vita+ is the fruit of Institut Rosell and Lallemand’s expertise in probiotics and high quality yeast-based health ingredients. It combines the synbiotic formula clinically documented to reduce common infections in children (1) and two vitamins recognized for their immune potential: vitamin D, from yeast-based ingredient Lalmin Vita D, and Vitamin C. Both vitamins have been granted immune-related health claims by EFSA. ProbioKid® Vita+ was unveiled at the Vitafoods Europe trade show that took place in early May in Geneva (Switzerland), where it raised much interest. ProbioKid® Vita+ is recommended to contribute to a healthy microflora balance, essential for the body's natural defenses.
ProbioKid® Vita+ is based on Institut Rosell-Lallemand’s clinically documented formula ProbioKid® and contains an optimal combination of three well-documented probiotic strains (Lactobacillus helveticus Rosell-52, Bifidobacterium bifidum Rosell-71, Bifidobacterium infantis Rosell-33),and a prebiotic (fructo oligo saccharide- FOS). In a randomized, double-blind, placebo-controlled pilot study presented in 2010 at the European Respiratory Society (ERS) congress and conducted in partnership with Laboratoires Urgo (France), this synbiotic formula showed the ability to significantly reduce the incidence of common winter infections (ENT, bronchopulmonary or gastric disorders) in school-aged children by 25%, as compared to placebo. In addition, there was a significant reduction of school absenteeism in children who took the synbiotic, a very good criterion according to the clinicians and an important benefit for parents. This lead the authors of the study to conclude to “a clinically relevant beneficial effect of a 3-month daily synbiotic regimen in preventing usual acute infectious illnesses, without carrying risk, in a school age population of 3-7year-olds.”
ProbioKid® Vita+ also contains vitamin D and C in adequate amounts (15%RDA) to bear immune-related EFSA health claims such as:
Contains/ Source of vitamin D that contributes to the normal function of the immune system and healthy inflammatory response (2).
Contains/ Source of vitamin C that has immunostimulating activities and that reduces tiredness and fatigue (3).
Indeed, certain studies have linked high occurrence of flu during the winter to vitamin D deficiency, and several European surveys have shown that up to 75% of the European population’s vitamin D intake could be below the recommended daily allowances (RDA). Vitamin C is also recognized for its immunostimulating capacities.
Finally, the vitamin D in ProbioKid® Vita+ is Lallemand’s LALMIN® VitaD Yeast, an inactivated dried whole cell yeast containing elevated and standardized levels of non-synthetic vitamin D2, produced by Lallemand thanks to a unique patented process involving the natural conversion by yeast cells of endogenous ergosterol.
About Lallemand and Institut Rosell
Lallemand Inc. is a privately owned Canadian company specializing in the development, production and marketing of yeast and bacteria, as well as other ingredients linked to these microorganisms or their markets. Institut Rosell has been part of the Lallemand Group since 1998. Today, it constitutes Lallemand’s Human Health and Nutrition Division and is dedicated to the selection, development, production and marketing of probiotic formulations for the food and pharmaceutical industries. With extensive experience in the culturing and production of live microorganisms since 1932, Institut Rosell conducts advanced research programs aimed at better understanding the properties, functions and beneficial effects of these probiotic formulations on health. For more information, visit www.institut-rosell-lallemand.com, or contact [email protected].
(1) Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv Respir Dis. 2010 Oct; 4(5):271-8. Epub 2010 Aug 20.
(2) EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010; 8(2):1468. [17 pp.]. doi:10.2903/j.efsa.2010.1468
(3) EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to vitamin C and reduction of tiredness and fatigue (ID 139, 2622), contribution to normal psychological functions (ID 140), regeneration of the reduced form of vitamin E (ID 202), contribution to normal energy-yielding metabolism (ID 2334, 3196), maintenance of the normal function of the immune system (ID 4321) and protection of DNA, proteins and lipids from oxidative damage (ID 3331) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1815. [20 pp.]. doi:10.2903/j.efsa.2010.1815.